Lynkuet joins Veozah as a nonhormonal option for vasomotor symptoms

The issue: Many women seek nonhormonal alternatives for menopausal hot flashes due to concerns about hormone replacement therapy.

Primary care relevance: Women now have two nonhormonal options for treating menopausal hot flashes, though both medications are more expensive than HRT and often require prior authorization.

Combined oral and topical therapy in male partners significantly reduces BV recurrence in females

The issue: Bacterial vaginosis recurrence is common; the role of partner treatment has been debated.

Why this study matters: Randomized controlled trial evaluating the effects of treating male partners of women with recurrent bacterial vaginosis.

Primary care relevance: Provides evidence on the benefits of treating male partners of women with recurrent bacterial vaginosis.

Study demonstrates effectiveness in reducing fracture risk in postmenopausal women aged 50–60

The issue: Early postmenopausal women at risk for osteoporosis need evidence on when and how to use bisphosphonates.

Why this study matters: This study demonstrated that zoledronate effectively reduced fracture risk in postmenopausal women aged 50 to 60.

Primary care relevance: Provides evidence on the benefits of zoledronate for fracture prevention in early postmenopausal women at risk.